Oesophageal Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with one of the following cancers (confirmed by laboratory testing): anus, bladder, breast, cervix, colon/rectum, endometrium, esophagus, gallbladder, head/neck, kidney, liver, lung, ovary, pancreas, prostate, sarcoma, or stomach.
• People who are starting outpatient chemotherapy aimed at curing their cancer, with treatment lasting at least 10 weeks, and who are enrolled before or during their second round of chemotherapy.
• People whose chemotherapy may be given alongside radiation, immunotherapy, or other targeted treatments (however, immunotherapy or monoclonal antibody treatment alone does not qualify).
• People receiving chemotherapy before or after surgery (neoadjuvant or adjuvant), or those receiving chemotherapy combined with radiation as their main treatment.
• People aged between 18 and 64 years old.
• People who were working at least 30 hours per week when they were diagnosed with cancer.
• People who are able to walk for 6 minutes, with or without a walking aid.
• People whose estimated walking fitness falls within a certain range, as measured by a standard walking test (a predicted distance of 550 metres or less in 6 minutes).
• People who are not currently training competitively in sports (such as running races or triathlons) and have not done regular progressive weight training twice a week for at least 3 months in the past year.
• People who are not currently taking part in another clinical trial focused on weight loss, physical activity, or diet.
• People who can read and understand English, as the study involves written materials and video-based coaching sessions.
• Clinical staff and research team members at participating sites who provide direct care to patients in this study and can speak and understand English are also eligible to participate as clinical stakeholders.
• Enrollment in other treatment or supportive care trials (not focused on exercise or weight loss) may be permitted with approval from the relevant study leadership (confirm with trial site).

Who may not be able to join:

• People whose cancer has spread to other parts of the body (metastatic cancer).
• People with serious heart, lung, or bone and joint conditions recorded in their medical records that would prevent moderate physical activity — for example, unstable chest pain, a recent heart attack, reliance on oxygen, or severe joint disease requiring imminent surgery (note: mild to moderate arthritis that still allows physical activity is not a reason for exclusion).
• People who are pregnant or breastfeeding, as the study involves chemotherapy during which breastfeeding is not considered safe, and includes remotely delivered exercise.
• People with current alcohol misuse, substance misuse, or dementia recorded in their medical records.
• People who are deaf or blind, as the study relies on being able to hear and see exercise demonstrations during video-based coaching sessions.

Important: Always verify eligibility with the trial site directly before applying.